CJC-1295: With and Without DAC - Research Comparison

Molecular Structure of CJC-1295

CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) that exhibits significant potential in therapeutic applications. It is designed to stimulate the release of growth hormone (GH) from the pituitary gland more effectively. The peptide exists in two forms: CJC-1295 with DAC (Drug Affinity Complex) and CJC-1295 without DAC. The molecular structure of CJC-1295 without DAC comprises 30 amino acids, while the DAC variant includes a lysine linkage to a maleimidoproprionic acid moiety, enhancing its half-life.

Mechanism of Action

CJC-1295 functions by binding to the GHRH receptors in the pituitary gland, promoting the pulsatile release of GH. The addition of DAC prolongs the half-life of the peptide by attaching to albumin, thereby extending its time of action up to two weeks. In contrast, the non-DAC version requires more frequent administration due to its shorter half-life.

Research Applications

Growth Hormone Stimulation

The primary research application for CJC-1295 is in the stimulation of growth hormone secretion. This has implications for muscle growth, aging, and recovery in clinical and athletic settings.

Potential Uses in Metabolic Disorders

Studies suggest a role in addressing metabolic disorders, such as obesity and type 2 diabetes, by improving metabolic rate and body composition.

Quality Markers to Look For

When assessing the quality of CJC-1295, researchers should consider several critical markers:

• Purity: High-performance liquid chromatography (HPLC) should indicate a purity of at least 98%.
• Sequence Verification: Mass spectrometry should confirm the correct amino acid sequence, especially the lysine linkage in DAC variants.
• Stability: Peptides should be stable under recommended storage conditions, with minimal degradation over time.

Common Impurities

Peptide synthesis can lead to various impurities, which can affect the efficacy and safety of research outcomes. Common impurities include:

• Truncated Sequences: Resulting from incomplete synthesis processes.
• Oxidation Products: Due to exposure to oxygen; cysteine oxidation is particularly notable.
• Residual Solvents: From the synthetic process, which should be minimized.

Storage Requirements

Proper storage of CJC-1295 is crucial to maintain its stability and efficacy:

• Temperature: Store at -20°C for long-term preservation. Short-term storage can be at 4°C.
• Light Protection: Peptides should be protected from light to prevent degradation.
• Lyophilized State: Maintaining the peptide in a lyophilized state can extend shelf life until reconstitution is necessary.

Comparison Between CJC-1295 With and Without DAC

Practical Tips for Researchers

• Always verify the peptide's certificate of analysis (CoA) to confirm purity and sequence accuracy.
• Consider the peptide's source and ensure it is from a reputable supplier with stringent quality control measures.
• Use protective gloves and a fume hood when handling peptides to prevent contamination and degradation.
• Reconstitute peptides using sterile water or appropriate buffers, and ensure pH levels are optimal for peptide stability.

Key Takeaways

• CJC-1295 is a potent GHRH analog, available with or without DAC, affecting its half-life and administration frequency.
• High purity and correct sequencing are crucial for effective research outcomes.
• Store peptides appropriately to maintain stability and prevent degradation.
• Understand the differences between DAC and non-DAC forms to select the appropriate variant for your research needs.